Cargando…
Male axillary accessory breast cancer: A case report
RATIONALE: Accessory breast cancer is extremely rare among all cancerous diseases, especially in male patients. There were only few male axillary accessory breast cancer cases that have been reported in scientific literatures so far. Hereby, we would like to discuss a case of male axillary accessory...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440245/ https://www.ncbi.nlm.nih.gov/pubmed/32176095 http://dx.doi.org/10.1097/MD.0000000000019506 |
_version_ | 1783573132173377536 |
---|---|
author | Bi, Minglei Li, Danyi Su, Yipeng Sun, Pengfei Gao, Yan |
author_facet | Bi, Minglei Li, Danyi Su, Yipeng Sun, Pengfei Gao, Yan |
author_sort | Bi, Minglei |
collection | PubMed |
description | RATIONALE: Accessory breast cancer is extremely rare among all cancerous diseases, especially in male patients. There were only few male axillary accessory breast cancer cases that have been reported in scientific literatures so far. Hereby, we would like to discuss a case of male axillary accessory breast cancer found in our hospital. PATIENT CONCERNS: We report a male senile patient suffering from a painful, enlarged, and hardened right axillary mass for more than 20 years. He came for further treatments due to progressive growth of the mass for 11 months with bloody ulceration for more than 1 month. DIAGNOSIS: Pathological examination manifested a grade II infiltrating ductal carcinoma derived from the accessory mammary gland (right axilla), with invasion of local skin. Immunohistochemical examination result: estrogen receptor (++) 90%, progesterone receptor (+++) 100%, human epidermal growth factor receptor-2 (1+), ki67 (20% positive), prostate specific antigen (−), caudal-related homeobox-2 (−), thyroid transcription factor-1 (−), Synaptophysin (+), NapsinA (1), and CK7 (−). INTERVENTIONS: Modified radical mastectomy and axillary lymph nodes clearance were performed on the accessary breast cancer under general anesthesia. Postoperatively, endocrine therapy was provided for the patient, orally-taken Letrozole was recommended for the rest of the patient's life. OUTCOMES: The patient recovered uneventfully and was discharged 3 days after the operation. The patient continued to take Letrozole orally regularly at home and no signs of recurrence were observed. CONCLUSION: Axillary accessory breast cancer in males is extremely rare, with no conspicuous and typical clinical presentations, which leads to inevitable neglect by clinicians. Therefore, there is significant necessity for clinicians to be cautious with this type of disease. |
format | Online Article Text |
id | pubmed-7440245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-74402452020-09-04 Male axillary accessory breast cancer: A case report Bi, Minglei Li, Danyi Su, Yipeng Sun, Pengfei Gao, Yan Medicine (Baltimore) 5700 RATIONALE: Accessory breast cancer is extremely rare among all cancerous diseases, especially in male patients. There were only few male axillary accessory breast cancer cases that have been reported in scientific literatures so far. Hereby, we would like to discuss a case of male axillary accessory breast cancer found in our hospital. PATIENT CONCERNS: We report a male senile patient suffering from a painful, enlarged, and hardened right axillary mass for more than 20 years. He came for further treatments due to progressive growth of the mass for 11 months with bloody ulceration for more than 1 month. DIAGNOSIS: Pathological examination manifested a grade II infiltrating ductal carcinoma derived from the accessory mammary gland (right axilla), with invasion of local skin. Immunohistochemical examination result: estrogen receptor (++) 90%, progesterone receptor (+++) 100%, human epidermal growth factor receptor-2 (1+), ki67 (20% positive), prostate specific antigen (−), caudal-related homeobox-2 (−), thyroid transcription factor-1 (−), Synaptophysin (+), NapsinA (1), and CK7 (−). INTERVENTIONS: Modified radical mastectomy and axillary lymph nodes clearance were performed on the accessary breast cancer under general anesthesia. Postoperatively, endocrine therapy was provided for the patient, orally-taken Letrozole was recommended for the rest of the patient's life. OUTCOMES: The patient recovered uneventfully and was discharged 3 days after the operation. The patient continued to take Letrozole orally regularly at home and no signs of recurrence were observed. CONCLUSION: Axillary accessory breast cancer in males is extremely rare, with no conspicuous and typical clinical presentations, which leads to inevitable neglect by clinicians. Therefore, there is significant necessity for clinicians to be cautious with this type of disease. Wolters Kluwer Health 2020-03-13 /pmc/articles/PMC7440245/ /pubmed/32176095 http://dx.doi.org/10.1097/MD.0000000000019506 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 5700 Bi, Minglei Li, Danyi Su, Yipeng Sun, Pengfei Gao, Yan Male axillary accessory breast cancer: A case report |
title | Male axillary accessory breast cancer: A case report |
title_full | Male axillary accessory breast cancer: A case report |
title_fullStr | Male axillary accessory breast cancer: A case report |
title_full_unstemmed | Male axillary accessory breast cancer: A case report |
title_short | Male axillary accessory breast cancer: A case report |
title_sort | male axillary accessory breast cancer: a case report |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440245/ https://www.ncbi.nlm.nih.gov/pubmed/32176095 http://dx.doi.org/10.1097/MD.0000000000019506 |
work_keys_str_mv | AT biminglei maleaxillaryaccessorybreastcanceracasereport AT lidanyi maleaxillaryaccessorybreastcanceracasereport AT suyipeng maleaxillaryaccessorybreastcanceracasereport AT sunpengfei maleaxillaryaccessorybreastcanceracasereport AT gaoyan maleaxillaryaccessorybreastcanceracasereport |